文献速递慢阻肺

慢阻肺与多病共存:认识并应对共病流行

COPD and multimorbidity: recognising and addressing a syndemic occurrence.
PubMed 文献 · Lancet Respir Med · 2023-09-08

多数慢阻肺患者至少合并一种其他临床相关慢性病,且多数死于非呼吸系统疾病(尤其心血管病和癌症)。作者主张将慢阻肺视为多病共存状态的一部分,而非单一疾病伴合并症,并引入共病流行概念解释某些疾病的聚集,提倡以患者为中心的整合管理。

要点

  • 多数慢阻肺患者合并至少一种其他慢性病,多数死于心血管病和癌症等非呼吸系统疾病。
  • 将慢阻肺视为多病共存状态的一部分,而非单一疾病伴合并症,有助于预防、诊断和管理。
  • 共病流行概念可解释慢阻肺患者中某些疾病的聚集,支持主动诊断、严重度评估和整合管理。

核心结论

  • 需要从将慢阻肺视为单一疾病伴合并症,转变为将慢阻肺视为多病共存状态的一部分,以推进疾病预防、诊断和管理。

主要发现

  • 大多数慢阻肺患者至少有一种其他临床相关慢性病。
  • 气流阻塞最严重的患者将死于呼吸衰竭,但大多数慢阻肺患者死于非呼吸系统疾病,尤其是心血管疾病和癌症。
  • 许多慢性病有共同危险因素,如衰老、吸烟、污染、缺乏活动和贫困。

临床怎么用

  • 对慢阻肺患者采取主动诊断、严重度评估和慢阻肺多病共存状态的整合管理,以患者为中心而非单一疾病方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer. As many chronic diseases have shared risk factors (eg, ageing, smoking, pollution, inactivity, and poverty), we argue that a shift from the current paradigm in which COPD is considered as a single disease with comorbidities, to one in which COPD is considered as part of a multimorbid state-with co-occurring diseases potentially sharing pathobiological mechanisms-is needed to advance disease prevention, diagnosis, and management. The term syndemics is used to describe the co-occurrence of diseases with shared mechanisms and risk factors, a novel concept that we propose helps to explain the clustering of certain morbidities in patients diagnosed with COPD. A syndemics approach to understanding COPD could have important clinical implications, in which the complex disease presentations in these patients are addressed through proactive diagnosis, assessment of severity, and integrated management of the COPD multimorbid state, with a patient-centred rather than a single-disease approach.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Fabbri LM, Celli BR, Agustí A, et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence. Lancet Respir Med. 2023. PMID: 37696283. doi:10.1016/S2213-2600(23)00261-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。